OTCMKTS:VASO - Vaso Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0343 0.00 (0.00 %) (As of 02/19/2019 06:13 AM ET)Previous Close$0.0347Today's Range$0.0310 - $0.034652-Week Range$0.02 - $0.1223Volume6,435 shsAverage Volume28,525 shsMarket Capitalization$6.07 millionP/E RatioN/ADividend YieldN/ABeta1.33 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Vaso Corporation operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, and GEHC and third party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment provides Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for physiological signals, such as ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsaion therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease, as well as in-service and training support. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was founded in 1987 and is headquartered in Plainview, New York. Receive VASO News and Ratings via Email Sign-up to receive the latest news and ratings for VASO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:VASO Previous Symbol CUSIPN/A Webwww.vasocorporation.com Phone516-997-4600Debt Debt-to-Equity Ratio0.09 Current Ratio0.55 Quick Ratio0.48Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$72.78 million Price / Sales0.08 Cash FlowN/A Price / Cash FlowN/A Book Value$0.05 per share Price / Book0.69Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-4,530,000.00 Net Margins-4.65% Return on Equity-46.63% Return on Assets-6.69%Miscellaneous Employees308 Outstanding Shares177,028,000Market Cap$6.07 million OptionableNot Optionable Vaso (OTCMKTS:VASO) Frequently Asked Questions What is Vaso's stock symbol? Vaso trades on the OTCMKTS under the ticker symbol "VASO." When is Vaso's next earnings date? Vaso is scheduled to release their next quarterly earnings announcement on Wednesday, February 20th 2019. View Earnings Estimates for Vaso. Has Vaso been receiving favorable news coverage? Press coverage about VASO stock has trended neutral on Tuesday, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Vaso earned a news sentiment score of 0.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the stock's share price in the near future. Who are some of Vaso's key competitors? Some companies that are related to Vaso include Precision Optics (PEYE), Digirad (DRAD), ENDRA Life Sciences (NDRA), Non-Invasive Monitoring Systems (NIMU), Aradigm (ARDM), CHF Solutions (CHFS), Nexeon Medsystems (NXNN), Reshape Lifesciences (RSLS), Escalon Medical (ESMC), Fc Global Realty (FCRE), Trimedyne (TMED), Magna-Lab (MAGAA), Guided Therapeutics (GTHP), SpectraScience (SCIE) and Newcardio (NWCI). Who are Vaso's key executives? Vaso's management team includes the folowing people: Dr. Jun Ma, Pres, CEO & Director (Age 56)Mr. Michael J. Beecher, CFO & Sec. (Age 74)Mr. Peter C. Castle, COO & Director (Age 51)Mr. Jonathan P. Newton, VP of Fin. & Treasurer (Age 58)Mr. Randy Hill, Consultant (Age 72) How do I buy shares of Vaso? Shares of VASO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Vaso's stock price today? One share of VASO stock can currently be purchased for approximately $0.0343. How big of a company is Vaso? Vaso has a market capitalization of $6.07 million and generates $72.78 million in revenue each year. Vaso employs 308 workers across the globe. What is Vaso's official website? The official website for Vaso is http://www.vasocorporation.com. How can I contact Vaso? Vaso's mailing address is 137 COMMERCIAL STREET SUITE 200, PLAINVIEW NY, 11803. The company can be reached via phone at 516-997-4600 or via email at [email protected] MarketBeat Community Rating for Vaso (OTCMKTS VASO)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 57 (Vote Outperform)Underperform Votes: 54 (Vote Underperform)Total Votes: 111MarketBeat's community ratings are surveys of what our community members think about Vaso and other stocks. Vote "Outperform" if you believe VASO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VASO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/19/2019 by MarketBeat.com StaffFeatured Article: What are the benefits of a balanced fund?